247P - Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experience

E.S Lutrino,L Orlando,G Giordano,C Zamagni,C Caliolo,A Febbraro,M Giampaglia,G Dima,A Quaranta,C Scavelli,D Bilancia,G Filippelli,C Fontanella,P Schiavone,P Fedele,M Enrica,D Rubino,S Cinieri

doi:10.1093/annonc/mdw365.26

247P - Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experience

E.S Lutrino, L Orlando + Show 16 more

Open Access

https://doi.org/10.1093/annonc/mdw365.26

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2016
Citations: 1	License type: elsevier-specific: oa user license

Affiliation: Ospedale A. Perrino, Policlinico S.Orsola-Malpighi, ASST Fatebenefratelli Sacco, Ospedale Santa Maria della Misericordia di Udine

#Pretreated HER2-positive Advanced Breast Cancer #Efficacy Of Eribulin + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

247P - Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experience

Full Text